サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：がん免疫療法市場：技術タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1335289

がん免疫療法市場：技術タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Cancer Immunotherapy Market with COVID-19 Impact Analysis, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 321 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
がん免疫療法市場：技術タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 321 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

がん免疫療法の市場規模は2022年に879億860万米ドルと評価され、2023年から2030年にかけて13.8%のCAGRで拡大

がん免疫療法市場-市場力学：

  • がん罹患率の増加とがん治療療法の技術的進歩の急増が、世界のがん免疫療法市場の成長を促進すると予想されます。
  • がん罹患率の拡大により、より効果的で個別化された治療法に対する需要が高まっています。がん免疫療法は、いくつかの種類のがんの治療において有望な結果を示しており、徐々に現代的ながん治療技術の重要な要素として見なされるようになってきています。疾病管理予防センターによると、米国では2020年に160万3,844人の新規がん患者が報告され、60万2,347人ががんで死亡しました。人口10万人あたり、403人の新規がん症例が報告され、144人ががんで死亡しました。2020年は、罹患率データが入手可能な最新の年です。がん研究の急速な技術進歩により、新規の治療薬やオーダーメイドの治療薬が生み出されています。特に免疫療法は、免疫チェックポイント阻害剤、CAR-T細胞療法、がんワクチン、腫瘍溶解性ウイルス、その他の革新的技術の出現により、かなりの進歩を遂げています。新興国のヘルスケア・インフラが加速すれば、がん免疫療法が採用される機会も増えると思われます。しかし、特に裕福でない国や地域では、高額な費用が多くの患者ががん免疫療法を受けることを妨げる可能性があります。

がん免疫療法市場-セグメンテーション分析：

  • がん免疫療法の世界市場は、製品タイプ、用途、エンドユーザー、地域によって区分されます。
  • 市場は製品タイプによって3つのカテゴリーに分けられる：すなわち、モノクローナル抗体、サイトカイン・免疫調節剤、その他です。モノクローナル抗体が市場を独占しています。モノクローナル抗体（mAbs）はがん免疫療法の一種であり、様々ながんの治療において不可欠な要素となっています。これらは、がん細胞のような危険な感染症と闘う免疫系の能力を模倣することができる実験室で作成された化合物です。
  • 市場は用途によって6つのカテゴリーに分けられる：肺がん、乳がん、大腸がん、メラノーマ、前立腺がん、頭頸部がん、その他です。肺がんは市場を独占しており、予測期間中もその優位性を維持するとみられます。免疫療法は、肺がん治療の選択肢を補完する重要なものとして浮上しています。化学療法と放射線療法は、長年にわたり肺がんの主な治療選択肢でした。
  • 市場はエンドユーザー別に病院、がん研究センター、クリニックの3つに分類されます。市場の成長を支配しているのは病院分野です。がん免疫療法は、小規模病院から大規模な大学医療機関まで、世界中の病院やクリニックで広く採用されています。

がん免疫療法市場-地理的洞察：

地理的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに区分されます。北米は、ヘルスケア支出の増加、がん罹患率の上昇、医療保険へのアクセスの急増により、市場の成長を支配すると予想されています。北米、特に米国は、世界のどの国よりも1人当たりのヘルスケア支出が多いです。このような高水準の支出のおかげで、公的部門も民間部門も、免疫療法など、斬新で高額になりがちながん治療に投資することができます。米国医師会によると、米国の医療費は2021年に2.7％増の4兆3,000億米ドル、国民1人当たり12,914ドルに達します。健康保険の有無は、患者がタイムリーで質の高い治療を受けられるかどうかに大きく影響します。欧州は、同地域におけるインフラの市場開拓とがん罹患率の上昇により、市場成長において2番目に大きな地域となっています。

がん免疫療法市場-競合情勢：

世界のがん罹患率の拡大と、特定のがんに対する免疫療法の有効性の確立により、がん免疫療法に対する需要が高まっています。この業界の企業プロファイルは、特定の治療法の有効性と安全性、治療可能な悪性腫瘍の範囲、価格設定、消費者に治療法の価値を示す能力などの要素で頻繁に競合します。新薬や適応症が競争上の優位性をもたらす可能性があるため、研究開発パイプラインの面でも競合します。この分野では近年大きな技術革新が起こっており、新しい治療法や技術の開発が進んでいます。例えば、ファイザー社は11月2022日、同社のがん免疫治療薬エラナタマブが再発または難治性の多発性骨髄腫（RRMM）の治療薬として米国食品医薬品局（FDA）から画期的治療薬指定を受けたと発表しました。

目次

第1章 がん免疫療法市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 がん免疫療法の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 がん免疫療法産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 がん免疫療法市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 がん免疫療法市場情勢

  • がん免疫療法市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 がん免疫療法市場- 技術タイプ別

  • 概要
    • テクノロジータイプ別のセグメントシェア分析
    • モノクローナル抗体
    • サイトカインと免疫調節物質
    • その他

第8章 がん免疫療法市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 肺がん
    • 乳がん
    • 結腸直腸がん
    • 黒色腫
    • 前立腺がん
    • 頭頸部がん
    • その他

第9章 がん免疫療法市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • がん研究センター
    • クリニック

第10章 がん免疫療法市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- がん免疫療法産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • AstraZeneca
    • Merck &Co., Inc
    • F. Hoffmann-La Roche Ltd
    • Bristol-Myers Squibb Company
    • Novartis AG
    • Lilly
    • Johnson &Johnson Services, Inc
    • Immunocore, Ltd

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Immunotherapy Market: Technology Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology Type
  • TABLE Global Cancer Immunotherapy Market, by Technology Type 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Immunotherapy Market, by Application 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cancer Immunotherapy Market, by End-User 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Immunotherapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Immunotherapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Technology Type segment market share analysis, 2022 & 2030
  • FIGURE Technology Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Europe Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Latin America Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Germany Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE India Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Brazil Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1564

REPORT HIGHLIGHT

The Cancer Immunotherapy Market size was valued at USD 87,908.6 Million in 2022, expanding at a CAGR of 13.8% from 2023 to 2030.

Cancer immunotherapy is a sort of cancer treatment that uses the body's own immune system to combat cancer. It works by assisting the immune system in recognizing and attacking cancer cells. Immunotherapy can be used alone or in conjunction with other cancer treatments. Cancer frequently overcomes many of the immune system's natural defenses, allowing cancer cells to proliferate. Different types of immunotherapy work in different ways. Some immunotherapy treatments assist the immune system block or limiting the growth of cancer cells. Others aid the immune system in destroying cancer cells or preventing cancer from spreading to other parts of the body. Immunotherapy has shown promise in treating a variety of cancers and has become a major focus of cancer research.

Cancer Immunotherapy Market- Market Dynamics:

  • The growing incidence of cancer and the surge in technological advancements in cancer treatment therapies are expected to propel the growth of the global cancer immunotherapy market.
  • The expanding cancer burden has produced a critical demand for more effective and tailored treatment alternatives. Cancer immunotherapy has demonstrated encouraging outcomes in treating several types of cancer and is gradually being regarded as an important component of modern cancer treatment techniques. According to the Centers for disease control and Prevention, In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available. Rapid technological advances in cancer research have resulted in the creation of novel and tailored medicines. Immunotherapy, in particular, has made considerable advances in recognition of the advent of immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, oncolytic viruses, and other innovative techniques. As healthcare infrastructure in emerging nations accelerates, there will be greater opportunities for cancer immunotherapies to be adopted. However, High expenses can prevent many patients from gaining Cancer Immunotherapy, particularly in less rich nations or regions.

Cancer Immunotherapy Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Immunotherapy market is estimated to grow annually at a CAGR of around 13.8% over the forecast period (2023-2030)
  • The Cancer Immunotherapy industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Lung Cancer was the leading type in 2022
  • Based on End-User segmentation, Hospitals was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Cancer Immunotherapy Market- Segmentation Analysis:

  • The Global Cancer Immunotherapy Market is segmented on the basis of Product Type, Application, End-User, and Region.
  • The market is divided into three categories based on product type: Monoclonal Antibodies, Cytokines & Immunomodulators, and Others. Monoclonal Antibodies dominate the market. Monoclonal antibodies (mAbs) are a type of cancer immunotherapy that has become an essential component in the treatment of various cancers. These are lab-created compounds that can imitate the immune system's ability to combat dangerous infections such as cancer cells.
  • The market is divided into six categories based on application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others. Lung Cancer dominates the market and is likely to maintain its dominance during the forecast period. Immunotherapy has emerged as an important complement to lung cancer treatment options. Chemotherapy and radiation were the principal treatment choices for lung cancer for many years.
  • The market is divided into three categories based on End-User: Hospitals, Cancer Research Centers, and Clinics. The hospital segment dominates the market growth. Cancer immunotherapy is widely employed in hospitals and clinics all over the world, from small hospitals to large university medical institutes.

Cancer Immunotherapy Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, owing to an increase in healthcare expenditure, a rise in the incidence of cancer, and a surge in access to medical insurance. North America, especially the United States, spends more per capita on healthcare than any other country in the world. Because of this high level of spending, both the public and commercial sectors can invest in novel and frequently expensive cancer treatments, such as immunotherapies. According to American Medical Association, Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD12,914 per capita. The availability of health insurance can have a substantial impact on a patient's capacity to receive timely and high-quality care. Europe is the second largest region for the growth of the market, owing to the development in the infrastructure in the region and rising incidences of cancer.

Cancer Immunotherapy Market- Competitive Landscape:

The expanding worldwide burden of cancer and the established efficacy of immunotherapies in treating specific forms of cancer have increased the demand for cancer immunotherapy. Companies in this industry frequently compete on factors such as particular treatments' efficacy and safety profile, the spectrum of malignancies their medications can treat, pricing, and their ability to demonstrate the value of their therapies to consumers. They compete in terms of their R&D pipelines as well, as novel medicines and indications can provide a competitive advantage. This field has seen major innovation in recent years, leading to the development of new therapies and techniques. For example, on November 2022, Pfizer Inc. nowadays announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the treatment of people with relapsed or refractory multiple myeloma (RRMM).

Recent Developments:

On June 2023, Merck, known as MSD outside of the United States and Canada, nowadays announced the U.S. Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck's anti-PD-1 therapy, in combination with standard of care chemotherapy for the treatment of patients with locally advanced unrespectable or metastatic biliary tract cancer (BTC).

Key features of the study:

  • This proposed research study on Cancer Immunotherapy market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Immunotherapy market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Immunotherapy market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Immunotherapy market
  • Impact of COVID-19 on Cancer Immunotherapy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Immunotherapy market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Immunotherapy market, we have also included competitive landscape and key innovator analysis for the Cancer Immunotherapy market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cancer Immunotherapy market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Immunotherapy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER IMMUNOTHERAPY MARKET KEY PLAYERS

  • Pfizer Inc.
  • AstraZeneca
  • Merck & Co., Inc
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Lilly
  • Johnson & Johnson Services, Inc
  • Immunocore, Ltd

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY TECHNOLOGY TYPE

  • Monoclonal Antibodies
  • Cytokines & Immunomodulators
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY APPLICATION

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY END-USER

  • Hospitals
  • Cancer Research Centers
  • Clinics

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Immunotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Immunotherapy Market Snippet by Technology Type
    • 2.1.2. Cancer Immunotherapy Market Snippet by Application
    • 2.1.3. Cancer Immunotherapy Market Snippet by End-User
    • 2.1.4. Cancer Immunotherapy Market Snippet by Country
    • 2.1.5. Cancer Immunotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Immunotherapy Key Market Trends

  • 3.1. Cancer Immunotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Immunotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Immunotherapy Market Opportunities
  • 3.4. Cancer Immunotherapy Market Future Trends

4. Cancer Immunotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Immunotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Immunotherapy Market Landscape

  • 6.1. Cancer Immunotherapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Immunotherapy Market - By Technology Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology Type, 2022 & 2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Cytokines & Immunomodulators
    • 7.1.4. Others

8. Cancer Immunotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Lung Cancer
    • 8.1.3. Breast Cancer
    • 8.1.4. Colorectal Cancer
    • 8.1.5. Melanoma
    • 8.1.6. Prostate Cancer
    • 8.1.7. Head & Neck Cancer
    • 8.1.8. Others

9. Cancer Immunotherapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Cancer Research Centers
    • 9.1.4. Clinics

10. Cancer Immunotherapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Immunotherapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Immunotherapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Immunotherapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Immunotherapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Immunotherapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cancer Immunotherapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. AstraZeneca
    • 11.2.3. Merck & Co., Inc
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. Bristol-Myers Squibb Company
    • 11.2.6. Novartis AG
    • 11.2.7. Lilly
    • 11.2.8. Johnson & Johnson Services, Inc
    • 11.2.9. Immunocore, Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us